Award

Development of potential anti-sarcopenia agents targeting the integrated stress response

Description: Sarcopenia is associated with increases the risk of physical limitation and lifestyle-related diseases. In current study, we aim to develop a new therapeutic strategy for the treatment of sarcopenia by targeting the integrated stress response (ISR). We performed a comprehensive gene expression analysis of skeletal muscle specific ISR transgenic mice and identified the ISR downstream target gene as a mediator of skeletal muscle atrophy. Skeletal muscle specific ISR defective mice were resistant to atrophy. Furthermore, we established the high-throughput assay to monitor the ISR activation, which allows us to identify the compounds modulating the ISR.
Amount: ¥17,810,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (B)
Start date: 2016-04-01
End date: 2019-03-31
Institutions: Tokushima University, The University of Tokushima
Funded outputs count: 14
Funder award ID: 16H05222
OpenAlex ID: G2017809779
2020 · Michael Briggs · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
2018 · Osamu Hashimoto, Masayuki Funaba, et al. · Cell Reports · 82
2018 · Satoshi Hisanaga, Masato Miyake, et al. · Scientific Reports · 22
2017 · Carina Fischer, Takahiro Seki, et al. · Nature Communications · 66
2017 · Kiyoe Kurahashi, Seika Inoue, et al. · Journal of Atherosclerosis and Thrombosis · 17
2017 · Masato Miyake, Masashi Kuroda, et al. · PLoS ONE · 17
2016 · Shusuke Taniuchi, Masato Miyake, et al. · Scientific Reports · 301